Rumi Scientific is a cutting-edge biotechnology company based in San Francisco, CA, dedicated to accelerating early-stage drug discovery for neurodevelopmental diseases. Their innovative technology utilizes predictive models of the human brain to identify new targets and drugs, revolutionizing the current approach and mitigating the risk of failure in therapeutic development.
With a focus on challenging and rare genetic diseases, Rumi Scientific's powerful discovery engine leverages the power of phenotype mining and artificial intelligence to tackle devastating neurological disorders. Their high-throughput organoid-like platform, known as neuroloids, mimics the development of the human brain, enabling the identification and quantification of differences between healthy and diseased cells. This groundbreaking technology predicts the therapeutic effects of potential drugs on diseased brain tissues, paving the way for novel discoveries in the treatment of genetic diseases.
Generated from the website